Cargando…
Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
BACKGROUND: Circulating tumor cells (CTCs) are liquid biopsies that represent micrometastatic disease and may offer unique insights into future recurrences in non-small cell lung cancer (NSCLC). Due to CTC rarity and limited stability, no stable CTC-derived xenograft (CDX) models have ever been gene...
Autores principales: | Suvilesh, Kanve N., Nussbaum, Yulia I., Radhakrishnan, Vijay, Manjunath, Yariswamy, Avella, Diego M., Staveley-O’Carroll, Kevin F., Kimchi, Eric T., Chaudhuri, Aadel A., Shyu, Chi-Ren, Li, Guangfu, Pantel, Klaus, Warren, Wesley C., Mitchem, Jonathan B., Kaifi, Jussuf T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917773/ https://www.ncbi.nlm.nih.gov/pubmed/35279152 http://dx.doi.org/10.1186/s12943-022-01553-5 |
Ejemplares similares
-
Tumor-Cell–Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2020) -
Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer
por: Nussbaum, Yulia I., et al.
Publicado: (2021) -
(18)F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancer
por: Avella, Diego M., et al.
Publicado: (2020) -
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018) -
PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2019)